SELLAS Life Sciences
SLS
SLS
24 hedge funds and large institutions have $4.89M invested in SELLAS Life Sciences in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
9% more funds holding
Funds holding: 22 → 24 (+2)
0.4% more ownership
Funds ownership: 10.59% → 10.99% (+0.4%)
Holders
24
Holding in Top 10
–
Calls
$3.18M
Puts
$45K
Top Buyers
| 1 | +$78.2K | |
| 2 | +$46.8K | |
| 3 | +$34.4K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$24.3K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$19K |
Top Sellers
| 1 | -$44.8K | |
| 2 | -$25K | |
| 3 | -$2.41K | |
| 4 |
Bank of New York Mellon
New York
|
-$140 |
| 5 |
VFA
Values First Advisors
Gray,
Tennessee
|
-$21 |